Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)

NCT00367822 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Restless Legs Syndrome

Interventions

DRUG: Lisuride
DRUG: Ropinirole
DRUG: Placebo

Sponsor

Axxonis Pharma AG